Saravanan SP

Dr. Saravanan SP


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2025 in Annals of Global Health
Verified
Journal Article
Open access
PDF file
DFDelfin Lovelina Francis
Delfin Lovelina Francis
SSSaravanan SP
Saravanan SP
Background: Oral cancer represents a critical global health equity challenge, with over 80% of cases occurring in low‑ and middle‑income countries (LMICs) and markedly lower survival rates in these regions compared to high‑income countries (HICs). Objective: To examine oral cancer disparities in LMICs through a global health equity lens by analyzing prevention strategies, early detection programs, and treatment access barriers, with the aim of identifying evidence‑based interventions to reduce these inequities. Methods: This comprehensive narrative review synthesized evidence from peer‑reviewed literature (2020–2025), including systematic reviews and reports from international health organizations. We searched PubMed, Web of Science, and Scopus using terms related to oral cancer, global health disparities, LMICs, prevention, screening, and treatment access. Results: Oral cancer demonstrates profound global disparities. LMICs bear ~82% of the global disease burden yet achieve five‑year survival rates of only 25–45%, compared to 65–85% in HICs. Key contributing disparities include the following: tobacco use remains high (LMICs account for 1.3 billion tobacco users) due to weak control programs. Limited human papillomavirus vaccination coverage is under 50% in most LMICs (vs. ~70–85% in HICs), and 70% of LMICs have no systematic oral cancer screening. In addition, 60–80% of oral cancer cases in LMICs present at advanced stages (vs. ~40–60% in HICs). They have severely limited access to surgery, radiotherapy, and chemotherapy (roughly 1 available service for every 5–10 needed). Conclusions: Addressing oral cancer disparities in LMICs requires comprehensive strategies, including strengthened tobacco control, cost‑effective screening programs using innovative technologies, task shifting to expand the health‑care workforce, and international partnerships to improve treatment infrastructure in resource‑poor settings. These combined efforts are essential to close the outcome gap and achieve global health equity in oral cancer care.

3 December 2022 in Journal of Global Health
Verified
Journal Article
Open access
DFDelfin Lovelina Francis
Delfin Lovelina Francis
SSSaravanan SP
Saravanan SP
Never-smokers are being diagnosed with lung cancer at an alarmingly increasing rate in Asian countries [1]. This trend is a major cause for concern. Lung cancer has been attributed to genetic susceptibility, occupational hazards, poor air quality due to pollution, second-hand smoking, however the logical explanation for third hand smoking (THS) is not well established. […]

2 June 2025 in Annals of Global Health
Verified
Journal Article
Open access
PDF file
DFDelfin Lovelina Francis
Delfin Lovelina Francis
SSSaravanan SP
Saravanan SP
ALAnitha Logaranjani
Anitha Logaranjani
SKSubramnayam S Sai Karthikeyan
Subramnayam S Sai Karthikeyan
MRMANISH RATHI
MANISH RATHI
Background: Marburg virus disease (MVD) is a highly virulent viral hemorrhagic fever with reported case fatality rates of up to 90%. It is part of the same family as the Ebola virus (Filoviridae). MVD, originally identified in 1967 in the context of outbreaks associated with African green monkeys, has been reported sporadically in Africa. Recent outbreaks, including those in Equatorial Guinea and Rwanda, underscore the need for robust preparedness systems and global response. Objectives: This narrative review focuses on the pathogenesis, clinical manifestations, diagnostic challenges and treatment strategies regarding MVD. It also stresses the need for better surveillance, diagnostic capabilities and vaccines to help prepare for future outbreaks. Methods: A comprehensive review of clinical data, epidemiological trends, and diagnostic developments was performed by searching relevant literature in PubMed, Medline and Scopus. The relevant data were extracted from studies on MVD and presented as a narrative review. Findings: MVD primarily affects immune and endothelial cells, resulting in a consequent cytokine storm, coagulopathy, and multi‑organ failure. Early symptoms such as fever, headache and myalgia are nonspecific and can delay diagnosis, as they mimic other infections. Monoclonal antibodies and newer antiviral agents are presently being evaluated for the management of MVD. Conclusions: MVD leads to significant morbidity and mortality, and the high fatality rate, along with the absence of targeted therapies, represents a serious global health threat. Collectively, the establishment of infrastructure for diagnostics, global collaboration, and advanced vaccine development will help bolster the response to MVD outbreaks and thus shorten periods of spiking mortality.

3 October 2025 in Annals of Global Health
Verified
Journal Article
Open access
PDF file
DFDelfin Lovelina Francis
Delfin Lovelina Francis
SSSaravanan SP
Saravanan SP
Introduction: Microplastics, plastic particles <5 mm in size, are a new class of environmental pollutants and have a role in systemic and oral health. Their implication in the pathogenesis of periodontal diseases has only recently been addressed. Objective: This review will discuss recent evidence of the modes of action by which microplastics may be involved in the onset and development of periodontal diseases. Methods: A systematic search of PubMed, Scopus, and Web of Science was performed up to May 2025 using keywords “microplastics,” “nanoplastics,” “oral health,” “periodontal disease,” “oxidative stress,” “dysbiosis,” “DNA damage response,” and “immune response” in the title, abstract, or keywords. According to PRISMA guidelines, 235 articles were retrieved, and 210 remained after duplicates were discarded. A total of 150 were removed after title/abstract screening. Sixty full‑text articles were reviewed, and 30 were included in the qualitative synthesis. Results: The existing evidence indicates that microplastics may induce periodontal pathology via several potential mechanisms, including (i) mechanical irritation of the surface of the gingival tissues, (ii) emission of toxic additives that cause oxidative stress, (iii) activation of DNA damage response (DDR) pathways, (iv) imbalance in the microbial community, and (v) immune regulation. These pathways intersect to enhance inflammation, tissue destruction, and dysbiosis, which culminate in the progression of periodontal disease. Conclusions: It is suggested that microplastics are one of the potential epiphenomena of periodontal diseases. However, original experimental data are limited, especially with reference to immunological interactions. Future in‑vitro and clinical investigations are urgently needed to confirm these mechanistic hypotheses and to foster preventive and therapeutic approaches.

18 August 2023 in Oral Diseases
Verified
Journal Article
Closed access
DFDelfin Lovelina Francis
Delfin Lovelina Francis
SSSaravanan SP
Saravanan SP
NKNavin Kaul
Navin Kaul
PJPrabhav Jain
Prabhav Jain
SKShreehari Ambika Krishnan
Shreehari Ambika Krishnan
SCSukhbir Singh Chopra
Sukhbir Singh Chopra